共 27 条
[1]
Tumor necrosis factor-related apoptosis-inducing ligand′s antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11. Gliniak B,Le T. Cancer Research . 1999
[2]
The TRAIL decoy receptor TRUNDD (DcR2,TRAIL-R4 ) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-,and KILLER/DR5-dependent colon cancer apoptosis. Meng RD,McDonald ER,Sheikh MS,et al. Molecular Therapy . 2000
[3]
Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types. Zhang XD,Nguyen T,Thomas WD,et al. FEBS Letters . 2000
[4]
Apo2 ligand/TNFrelated apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells. Gong B,Almasan A. Cancer Research . 2000
[5]
Adenoviral-mediated transfer of the TNFrelated apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis. Griffith TS,Anderson RD,Davidson BL. J Immunol . 2000
[6]
Human brain-cell death induced by tumournecrosis-factor-related apoptosis-inducing ligand. Nitsch R,Bechmann I,Deisz RA,et al. The Lancet . 2000
[7]
New insights into p53 regulation and gene therapy for cancer. Zeimet AG,Riha K,Berger J,et al. Biochemical Pharmacology . 2000
[8]
NFkappaB kinetics predetermine TNF-alpha sensitivity of colorectal cancer cells. Zwacka RM,Stark L,Dunlop MG. The Journal of Genetic Medicine . 2000
[9]
Expression and antitumor effects of TRAIL in human cholangiocarcinoma. Tanaka S,Sugimachi K,Shirabe K,et al. Hepatology . 2000
[10]
Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL. Gibson SB,Oyer R,Spalding AC,et al. Molecular and Cellular Biology . 2000